| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.038 | 0.5 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.5 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.5 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | 0.13 | 0.5 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | -0.12 | 0.5 |